---
title: Saliva metabolomic profile of COVID-19 patients associates with disease severity
date: '2022-10-22'
linkTitle: http://link.springer.com/10.1007/s11306-022-01936-1
source: Latest Results for Metabolomics
description: ' <h3 class="a-plus-plus">Abstract</h3> <span class="a-plus-plus abstract-section
  id-a-sec1"> <h3 class="a-plus-plus">Introduction</h3> <p class="a-plus-plus">Coronavirus
  disease 2019 (COVID-19) is strongly linked to dysregulation of various molecular,
  cellular, and physiological processes that change abundance of different biomolecules
  including metabolites that may be ultimately used as biomarkers for disease progression
  and severity. It is important at early stage to readily distinguish those patients
  that are likely to progress to moderate and severe stages.</p> </span> <span ...'
---
 <h3 class="a-plus-plus">Abstract</h3> <span class="a-plus-plus abstract-section id-a-sec1"> <h3 class="a-plus-plus">Introduction</h3> <p class="a-plus-plus">Coronavirus disease 2019 (COVID-19) is strongly linked to dysregulation of various molecular, cellular, and physiological processes that change abundance of different biomolecules including metabolites that may be ultimately used as biomarkers for disease progression and severity. It is important at early stage to readily distinguish those patients that are likely to progress to moderate and severe stages.</p> </span> <span ...